MedPath

A prospective study on The additive effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonate under phototherapy

Not Applicable
Conditions
Indirect hyperbilirubinemia in neonate.
Physiological jaundice (intense)(prolonged) NOS
Registration Number
IRCT2013020512370N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

birth-weight 2500-4000 gr; gestational age between 38-41 weeks; breastfeeding neonate; total bilirubin 14-20 mg/dl and neonates age older than three days.
Exclusion criteria: infants with incompatible ABO, Rh; G6PD deficiency; direct hyper billirubinemia; septicemia or diseases that are implicated in causing jaundice; premature infants; infants of diabetic mothers.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of need phototherapy. Timepoint: Since start study till finish study. Method of measurement: Timer.
Secondary Outcome Measures
NameTimeMethod
Serum total bilirubin. Timepoint: Since start study &12, 24, 36, 48 hour. Method of measurement: Blood sample.
© Copyright 2025. All Rights Reserved by MedPath